Did some work this week on covalent inhibitors, made famous by For Blood and Money and for being the first drugs to successfully target RAS
It's a pretty fascinating class of molecules, both b/c they were shunned for an extended period of time and b/c binding affinity and pharmacokinetics have an altered importance compared to traditional small molecules